These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10973842)

  • 1. Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy.
    Stangl K; Dschietzig T; Richter C; Laule M; Stangl V; Tanis E; Baumann G; Felix SB
    Circulation; 2000 Sep; 102(10):1132-8. PubMed ID: 10973842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cessation of pulmonary and coronary secretion of adrenomedullin peptides in the progression of human heart failure.
    Stangl K; Dschietzig T; Richter C; Stangl V; Bartsch C; Zurbrügg HR; Pregla R; Baumann G; Felix SB; Laule M
    Horm Metab Res; 2002 Feb; 34(2):81-6. PubMed ID: 11972292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure.
    Givertz MM; Colucci WS; LeJemtel TH; Gottlieb SS; Hare JM; Slawsky MT; Leier CV; Loh E; Nicklas JM; Lewis BE
    Circulation; 2000 Jun; 101(25):2922-7. PubMed ID: 10869264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension.
    Wilkens H; Bauer M; Forestier N; König J; Eichler A; Schneider S; Schäfers HJ; Sybrecht GW
    Circulation; 2003 Mar; 107(11):1509-13. PubMed ID: 12654608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.
    Dschietzig T; Bartsch C; Pregla R; Zurbrügg HR; Armbruster FP; Richter C; Laule M; Romeyke E; Neubert C; Voelter W; Baumann G; Stangl K
    Regul Pept; 2002 Dec; 110(1):33-8. PubMed ID: 12468107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary constriction and consequent cardiodepression in pulmonary embolism are mediated by pulmonary big endothelin and enhanced in early endothelial dysfunction.
    Dschietzig T; Laule M; Alexiou K; Schrör K; Baumann G; Stangl K
    Crit Care Med; 1998 Mar; 26(3):510-7. PubMed ID: 9504580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans.
    Pernow J; Kaijser L; Lundberg JM; Ahlborg G
    Circulation; 1996 Nov; 94(9):2077-82. PubMed ID: 8901654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
    Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
    Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators.
    Spieker LE; Mitrovic V; Noll G; Pacher R; Schulze MR; Muntwyler J; Schalcher C; Kiowski W; Lüscher TF
    J Am Coll Cardiol; 2000 Jun; 35(7):1745-52. PubMed ID: 10841220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?
    Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
    Heart Fail Rev; 2001 Dec; 6(4):301-15. PubMed ID: 11447305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endothelin in chronic heart failure.
    McMurray JJ; Ray SG; Abdullah I; Dargie HJ; Morton JJ
    Circulation; 1992 Apr; 85(4):1374-9. PubMed ID: 1532540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF.
    Kjekshus H; Smiseth OA; Klinge R; Oie E; Hystad ME; Attramadal H
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1299-310. PubMed ID: 10749728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of nitroglycerin on plasma calcitonin gene-related peptide and endothelin in congestive heart failure].
    Yu ZX; Ou SQ; Lü YZ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):251-4. PubMed ID: 14653081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating endothelins are not of cardiopulmonary origin in heart failure patients.
    Wang YZ; Goetze JP; Videbaek R; Rehfeld JF; Kastrup J
    Scand J Clin Lab Invest; 2005; 65(4):341-7. PubMed ID: 16076689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients.
    Ottosson-Seeberger A; Ahlborg G; Hemsén A; Lundberg JM; Alvestrand A
    J Am Soc Nephrol; 1999 May; 10(5):1037-44. PubMed ID: 10232690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma levels of ET-1 and its precursor, big ET-1, in the arterial and venous circulation following double myocardial ischemia-reperfusion injury in dogs.
    Battistini B; Kingma JG
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S215-20. PubMed ID: 11078381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure.
    Onishi K; Ohno M; Little WC; Cheng CP
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1214-22. PubMed ID: 10027861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure.
    Tsutamoto T; Wada A; Hisanaga T; Maeda K; Ohnishi M; Mabuchi N; Sawaki M; Hayashi M; Fujii M; Kinoshita M
    J Am Coll Cardiol; 1999 Feb; 33(2):530-7. PubMed ID: 9973035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.